Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation

被引:32
|
作者
El-Salamouni, Noha S. [1 ]
Farid, Ragwa M. [1 ,2 ]
El-Kamel, Amal H. [2 ]
El-Gamal, Safaa S. [2 ]
机构
[1] Pharos Univ Alexandria, Dept Pharmaceut, Fac Pharm & Drug Mfg, Alexandria, Egypt
[2] Alexandria Univ, Dept Pharmaceut, Fac Pharm, Alexandria, Egypt
关键词
Glaucoma; nanostructured lipid carriers; solid lipid nanoparticles; ocular targeting; ocular histology; brimonidine; OCULAR DRUG-DELIVERY; NANOPARTICLES SLN; CAPRA-HIRCUS; PART II; DESIGN; EYE; MATRICES; RELEASE; SYSTEM; GATIFLOXACIN;
D O I
10.1080/02652048.2018.1425753
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Brimonidine ocular hypotensive effect can be enhanced by increasing residence time and corneal penetration. The current work aimed to formulate, evaluate and compare nanostructured lipid carriers (NLCs) to solid lipid nanoparticles (SLNs) and commercial eye drops for controlled brimonidine delivery. NLCs prepared by modified high shear homogenisation were spherical with a mean size of 151.97 +/- 1.98nm, negative zeta potential (ZP) of -44.2 +/- 7.81mV, % entrapment efficiency (EE) of 83.631 +/- 0.495% and low crystallinity index (CI) (17.12%), indicating a better drug incorporation. Moreover, they kept stable during storage at 4 degrees C for 3months. Permeability coefficient of NLCs was 1.227 folds higher than that of SLNs. Histological examination revealed localisation of NLCs in the anterior ocular chamber. NLCs revealed the most sustained and highest intraocular pressure (IOP) lowering activity (-13.14 +/- 1.28mmHg) in rabbits. In conclusion, NLCs is a promising approach for IOP reduction compared to eye drops and SLNs.
引用
收藏
页码:102 / 113
页数:12
相关论文
共 50 条
  • [31] Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation
    Abdelmonem, Rehab
    Al-Samadi, Inas Essam Ibrahim
    El Nashar, Rasha M.
    Jasti, Bhaskara R.
    El-Nabarawi, Mohamed A.
    DRUG DELIVERY, 2022, 29 (01) : 2868 - 2882
  • [32] IN-VITRO AND IN-VIVO
    不详
    NATURE, 1972, 239 (5368) : 132 - &
  • [33] Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product
    Din, Fakhar Ud
    Zeb, Alam
    Shah, Kifayat Ullah
    Zia-ur-Rehman
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 51 : 583 - 590
  • [34] INTRAOCULAR SILICONE OIL - IN-VITRO AND IN-VIVO MR AND CT CHARACTERISTICS
    MATHEWS, VP
    ELSTER, AD
    BARKER, PB
    BUFF, BL
    HALLER, JA
    GREVEN, CM
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1994, 15 (02) : 343 - 347
  • [35] Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting: Formulation development, optimization and In-Vivo preclinical evaluation
    Noorulla, K. M.
    Yasir, Mohd
    Muzaffar, Faizi
    Roshan
    Ghoneim, Mohammed M.
    Almurshedi, Alanood S.
    Tura, Abdurazak J.
    Alshehri, Sultan
    Gebissa, Teshome
    Mekit, Shimelis
    Ahmed, Mohammed Muqtader
    Zafar, Ameeduzzafar
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 67
  • [36] DEVELOPMENT OF FLOATING DRUG DELIVERY SYSTEM FOR LORATADINE: IN-VITRO AND IN-VIVO EVALUATION
    Sapavatu, Srinu Naik
    Jadi, Rajendra Kumar
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (06): : 3021 - 3032
  • [37] Novel biomimetic nanostructured lipid carriers for cancer therapy: preparation, characterization, and in vitro/in vivo evaluation
    Zhou, Jianwen
    Guo, Biru
    Zhu, Wenquan
    Sui, Xiaoyu
    Ma, Xiaoxing
    Qian, Jiayi
    Cao, Lixin
    Han, Cuiyan
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2021, 26 (01) : 81 - 91
  • [38] Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation
    Polat, Heybet Kerem
    Kurt, Nihat
    Aytekin, Eren
    cayli, Yagmur Akdag
    Pehlivan, SibelBozdag
    calis, Sema
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 38 (06) : 412 - 423
  • [39] Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation
    Li, Min
    Pei, Jianying
    Ma, Zhenzhen
    Fu, Juntao
    Chen, Feifan
    Du, Shuzhang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (04) : 731 - 739
  • [40] Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation
    Min Li
    Jianying Pei
    Zhenzhen Ma
    Juntao Fu
    Feifan Chen
    Shuzhang Du
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 731 - 739